Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Acq. announced Consulting agrmnt
|
BRAIN SCIENTIFIC INC. (BRSF)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/05/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/20/2023 |
8-K
| Quarterly results |
02/14/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
02/06/2023 |
8-K
| Quarterly results |
01/18/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
01/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/02/2022 |
8-K
| Quarterly results |
08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/11/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
08/04/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
07/19/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
07/05/2022 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
06/24/2022 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
06/15/2022 |
8-K
| Quarterly results |
05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
04/19/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
04/06/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
03/31/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
02/16/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
02/14/2022 |
SC 13G/A
| Caleca Thomas reports a 4.7% stake in Brain Scientific Inc. |
02/14/2022 |
SC 13G/A
| BROWN ANDREW M reports a 5.1% stake in Brain Scientific Inc. |
02/08/2022 |
8-K
| Quarterly results |
01/13/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
01/13/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
12/28/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
12/15/2021 |
8-K/A
| Quarterly results |
12/02/2021 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
11/10/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/27/2021 |
SC 13D
| kotob Hassan reports a 18.8% stake in BRAIN SCIENTIFIC INC. |
10/18/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
10/07/2021 |
8-K
| Acquisition/merger/asset purchase announced
Docs:
|
"AMENDMENT TO AGREEMENT AND PLAN OF MERGER",
"PIEZO MOTION CORP.",
"FORM OF COMMON STOCK PURCHASE WARRANT (OCTOBER 2021)",
"ASSIGNMENT AND ASSUMPTION AGREEMENT ASSIGNMENT AND ASSUMPTION AGREEMENT, dated as of October 1, 2021, by and between Brain Scientific Inc., a Nevada corporation , and MemoryMD, Inc., a Delaware corporation . INTRODUCTION WHEREAS, the Assignor contemplates entering into a business combination on the date hereof, pursuant to which, among other things, Piezo Motion Corp., a Delaware corporation, will merge with a newly-formed wholly-owned subsidiary of the Assignor with Piezo as the surviving corporation ; WHEREAS, in preparation for the transactions contemplated by the Business Combination, the Assignor is required to contribute and assign any and all rights, title, and interest to all assets and liabilities, to the extent assignable, which pertain to the operations of Assignor, in effect or...",
"FORM OF 10% CONVERTIBLE PROMISSORY NOTE (OCTOBER 2021)",
"EXECUTIVE EMPLOYMENT AGREEMENT",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)",
"ASSIGNMENT AGREEMENT",
"Brain Scientific and Piezo Motion Complete Merger and Announce Hassan Kotob as CEO of the Combined Company The company also announced the closing of a $5 million financing round from U.S. institutions. Both parties to combine their proprietary technology and introduce innovative products. NEW YORK, Oct. 04, 2021 -- via InvestorWire - Neurology-focused medical device and software company Brain Scientific Inc. and Piezo Motion Corp., a leading innovator of high-precision motion technology, have closed their previously announced merger agreement. Upon the closing of the merger on Oct. 1, 2021, Hassan Kotob became the Chairman and CEO of the combined company. Prior to Piezo Motion Corp., Kotob founded North Plains Systems Corp., where he also served as Chairman and CEO and later led a successf..." |
|
|
|
|